| Entry |
|
|---|
| Name |
Norlevorphanol (INN) |
|---|
| Formula |
C16H21NO
|
|---|
| Exact mass |
243.1623
|
|---|
| Mol weight |
243.34
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
Analgesic
DG01984 Opioid analgesics
|
|---|
| Efficacy |
Analgesic (narcotic), Opioid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
D12692 Norlevorphanol
Analgesic
DG01984 Opioid analgesics
D12692 Norlevorphanol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D12692 Norlevorphanol (INN)
Narcotics and psychotropics in Japan [br08308.html]
Narcotics by Control Act Article 2 Table 1 (76 substances)
D12692
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C1z C 17.3568 -16.6569
2 C1y C 18.5466 -17.3568
3 C8y C 17.3568 -15.3272
4 C1x C 18.5466 -16.0270
5 C1x C 16.2370 -17.3568
6 C1y C 19.7364 -16.6569
7 C1x C 18.5466 -18.6866
8 C8y C 18.5466 -14.6273
9 C8x C 16.1670 -14.6273
10 C1x C 16.2370 -18.6866
11 C1x C 19.7364 -15.3272
12 N1x N 20.9261 -17.3568
13 C1x C 17.4268 -19.3864
14 C8x C 18.5466 -13.2975
15 C8y C 16.1670 -13.2975
16 C8x C 17.3568 -12.5977
17 O1a O 15.0472 -12.5977
18 C1x C 20.9260 -15.9461
BOND 21
1 1 2 1
2 1 3 1
3 1 4 1 #Up
4 1 5 1
5 2 6 1
6 2 7 1
7 3 8 2
8 3 9 1
9 5 10 1
10 6 11 1
11 6 12 1 #Up
12 7 13 1
13 8 14 1
14 9 15 2
15 14 16 2
16 15 17 1
17 8 11 1
18 10 13 1
19 15 16 1
20 12 18 1
21 4 18 1
|
|---|
